This post was originally published on this site The Committee for Medicinal Products for Human Use (CHMP), a branch of the European Medicines Agency (EMA), has recommended that two regimens of Keytruda (pembrolizumab) be approved in Europe for first-line treatment of metastatic or inoperable recurrent head and neck squamous cell carcinoma (HNSCC). The CHMP recommends that…
This post was originally published on this site Daiichi Sankyo has submitted an application to Japanese regulatory authorities asking that its investigational therapy trastuzumab deruxtecan (DS-8201) be approved as a treatment for people with HER2-positive metastatic breast cancer. The New Drug Application (NDA) is based on results from the multi-center, randomized, open-label DESTINY-Breast01 Phase 2…
This post was originally published on this site The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Cleveland Diagnostics’ IsoPSA, a minimally invasive blood test for early detection of prostate cancer. The IsoPSA test works by identifying cancer-related structural changes in a key protein. The breakthrough device designation is awarded to…
This post was originally published on this site A newly developed imaging approach that combines laser microscopy with computational analysis may make it easier to spot ovarian cancer cells that have spread to other organs, called metastasis, a study found. The new technique was described in a paper, titled “Two-photon images reveal unique texture features…
This post was originally published on this site A Phase 2 clinical trial assessing Solasia Pharma’s lead candidate darinaparsin as a treatment for relapsed or refractory peripheral T-cell lymphoma (PTCL) in Asian patients has reached its target enrollment, the company announced. The Asian multinational study (NCT02653976) has recruited 67 patients across 24 sites in Japan,…
This post was originally published on this site AstraZeneca‘s Imfinzi (durvalumab) decreases the spread of cancer to other parts of the body, explaining the enhanced survival in patients with stage 3 inoperable non-small-cell lung cancer (NSCLC), according to a new analysis of Phase 3 data. This analysis of survival data was gathered from the Phase 3…
This post was originally published on this site Radiotherapy plans generated with machine learning in the RayStation system are now being used at the Princess Margaret Cancer Centre, in Canada, to treat men with localized prostate cancer. RayStation is a treatment planning system (TPS) to optimize care for cancer patients. It combines features such as…
This post was originally published on this site The search for a cure for ovarian cancer has been given a boost by a $5 million gift that will support the clinical research of David S. Alberts, MD, an expert in the field of ovarian cancer research and treatment at the University of Arizona (UA) College…
This post was originally published on this site Multiple myeloma patients treated in their community by local oncologists have poorer survival outcomes than those receiving care at centers that see large numbers of patients or are nationally recognized, and likely to have doctors with more experience in this disease, a study reports. Its findings were…
This post was originally published on this site Depression and anxiety may worsen the quality of life and lung function of patients with pulmonary sarcoidosis, a study has found. The findings of the study, “Psychological burden associated with worse clinical outcomes in sarcoidosis,” were published in the journal BMJ Open Respiratory Research. Statistics indicate that…
